Prophylactic N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomised, double-blinded, placebo-controlled clinical trial
- PMID: 12682719
- DOI: 10.1007/s00134-003-1723-1
Prophylactic N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomised, double-blinded, placebo-controlled clinical trial
Abstract
Objective: Our objective was to investigate whether short-term infusion of the oxygen free radical scavenger N-acetylcysteine (NAC) administered before and during extensive abdominal surgery could ameliorate the progression of early systemic inflammatory response.
Design: Prospective, randomised, double-blinded, placebo-controlled clinical trial.
Setting: Twenty-bed intensive care unit in a university hospital.
Patients: Following written informed consent, 100 patients were randomised into NAC and placebo groups. Three patients from the NAC group and four from the placebo group withdrew before the final analysis.
Intervention: The treatment group (n=47) received NAC (150 mg/kg(-1) bolus followed by a continuous infusion of 12 mg/kg(-1)/h(-1)) and the placebo group ( n=46) received the same volume of 5% dextrose during surgery.
Measurements and results: Serum procalcitonin (PCT), C-reactive protein (CRP) and microalbuminuria was monitored preoperatively, on admission to ICU, then daily during the first 3 postoperative days. For statistical analysis Mann Whitney and Chi-squared tests were used. Patients' clinical course was similar in each group as monitored by the Multiple Organ Dysfunction Scores. There was no significant difference between the two groups regarding PCT and microalbuminuria at any assessment point. Significantly lower CRP levels were found in the NAC group on days 1 and 2 (t(24): median: 84.5 interquartile range: [62-120] vs. 118 [86-137] mg/l; p=0.020; t(48): 136 [103-232] vs. 195 [154-252] mg/l; p=0.013, NAC vs. placebo respectively).
Conclusion: In this study, short-term NAC treatment decreased CRP levels, but failed to attenuate any other inflammatory response, as monitored by serum PCT and microalbuminuria. Overall, our results do not support the routine prophylactic use of NAC as a free radical scavenger in abdominal surgery.
Similar articles
-
[Effect of prophylactic N-acetylcysteine on postoperative organ dysfunction and inflammatory markers after major abdominal surgery for cancer. Prospective, randomized, double-blind, placebo-controlled clinical trial].Magy Seb. 2002 Dec;55(6):369-74. Magy Seb. 2002. PMID: 12616822 Clinical Trial. Hungarian.
-
Lack of effect of prophylactic N-acetylcysteine on postoperative organ dysfunction following major abdominal tumour surgery: a randomized, placebo-controlled, double-blinded clinical trial.Anaesth Intensive Care. 2003 Jun;31(3):267-71. doi: 10.1177/0310057X0303100304. Anaesth Intensive Care. 2003. PMID: 12879670 Clinical Trial.
-
N-Acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study.Crit Care Med. 1999 Jun;27(6):1100-4. doi: 10.1097/00003246-199906000-00028. Crit Care Med. 1999. PMID: 10397212 Clinical Trial.
-
N-Acetylcysteine's Role in Sepsis and Potential Benefit in Patients With Microcirculatory Derangements.J Intensive Care Med. 2018 Feb;33(2):87-96. doi: 10.1177/0885066617696850. Epub 2017 Mar 16. J Intensive Care Med. 2018. PMID: 28299952 Review.
-
Deciphering the oxyradical inflammation Rosetta stone: O2*-NO*, OONO-, polymorphonuclear neutrophils, poly(ADP-ribose) synthetase, systemic inflammatory response syndrome, and multiple organ dysfunction syndrome.Crit Care Med. 1999 Aug;27(8):1666-9. doi: 10.1097/00003246-199908000-00058. Crit Care Med. 1999. PMID: 10470790 Review. No abstract available.
Cited by
-
Preventing the development of severe COVID-19 by modifying immunothrombosis.Life Sci. 2021 Jan 1;264:118617. doi: 10.1016/j.lfs.2020.118617. Epub 2020 Oct 20. Life Sci. 2021. PMID: 33096114 Free PMC article. Review.
-
Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2).Crit Care. 2013 Feb 4;17(1):205. doi: 10.1186/cc11455. Crit Care. 2013. PMID: 23394215 Free PMC article. Review.
-
Year in review in intensive care medicine: 2003. II. Brain injury, hemodynamics, gastrointestinal tract, renal failure, metabolism, trauma, and postoperative.Intensive Care Med. 2004 Jul;30(7):1266-75. doi: 10.1007/s00134-004-2339-9. Epub 2004 Jun 15. Intensive Care Med. 2004. PMID: 15221133 Review. No abstract available.
-
Section 4: Contrast-induced AKI.Kidney Int Suppl (2011). 2012 Mar;2(1):69-88. doi: 10.1038/kisup.2011.34. Kidney Int Suppl (2011). 2012. PMID: 25018920 Free PMC article. No abstract available.
-
Supplemental N-acetylcysteine and other measures that boost intracellular glutathione can downregulate interleukin-1β signalling: a potential strategy for preventing cardiovascular events?Open Heart. 2017 Jul 28;4(2):e000599. doi: 10.1136/openhrt-2017-000599. eCollection 2017. Open Heart. 2017. PMID: 28878946 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous